Paul C. D. Bank

Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact

Cathelijne H. van der Wouden, Paul C. D. Bank, Kübra Özokcu et al. · Genes · 2019 · 74 citations · Full text

Medicine, Community Pharmacy, Pharmacology +17

A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care

Paul C. D. Bank, Jesse J. Swen, Rowena D. Schaap et al. · European Journal of Human Genetics · 2019 · 54 citations · Full text

Medicine, Clinical Pharmacy, Pharmacology +16

The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complications

Paul C. D. Bank, Leo Jacobs, Sjoerd A.A. van den Berg et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2020 · 46 citations · Full text

Law, Health Law, Clinical Research Regulation +11

The effect of complementary and alternative medicines on CYP3A4-mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel

Kim D. Mooiman, Roel F. Maas-Bakker, Jeroen J. M. A. Hendrikx et al. · Journal of Pharmacy and Pharmacology · 2014 · 35 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17